The value of cardiac magnetic resonance delayed enhancement combined with tissue tracking in discriminating cardiac amyloidosis from hypertrophic cardiomyopathy
PurposeCardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) may both present with left ventricular hypertrophy, making differential diagnosis challenging. This study aimed to evaluate the value of cardiac magnetic resonance (CMR) delayed enhancement combined with tissue tracking (CMR-TT) i...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2025-12-01
|
| Sraith: | Frontiers in Cardiovascular Medicine |
| Ábhair: | |
| Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1712928/full |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
